XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $299K invested in XTL Biopharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$31.3K |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$15.8K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $238K | 198,888 | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $31.3K | 25,211 | +25,211 | New |
|
|
3
Morgan Stanley
New York
| $15.8K | 13,251 | -5,100 | -28% |
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $13.6K | 10,954 | – | – |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|